This company has been marked as potentially delisted and may not be actively trading. NASDAQ:IMRA IMARA (IMRA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsInsider TradesTrendsBuy This Stock About IMARA Stock (NASDAQ:IMRA) 30 days 90 days 365 days Advanced Chart Get IMARA alerts:Sign Up Key Stats Today's Range$37.88▼$40.0050-Day Range$6.32▼$25.2852-Week Range$0.97▼$6.32Volume7,723 shsAverage Volume138,364 shsMarket Capitalization$1.01 billionP/E Ratio768.95Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2-related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts. Read More Receive IMRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IMARA and its competitors with MarketBeat's FREE daily newsletter. Email Address IMRA Stock News HeadlinesBitwise Announces Monthly Distributions for IMST, ICOI, IMRA, and IGMEJuly 24, 2025 | businesswire.comImara overcoming infertility, am I appalled with blood on my face, is it a pregnancy symptom?May 20, 2025 | msn.comToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at screens all day. Just enter near the close, exit the next morning—and move on. Some trades have hit 200%+ overnight.August 2 at 2:00 AM | Timothy Sykes (Ad)Imran Khan opens up on his comparisons to Ranbir Kapoor: 'I never considered...'May 11, 2024 | msn.comImara BlumeAugust 23, 2023 | health.usnews.comIMARA Inc. (IMRA) Stock Historical Prices & Data - Yahoo FinanceMarch 3, 2023 | finance.yahoo.comImara Announces Stockholder Approval of Merger With EnlivenFebruary 22, 2023 | finance.yahoo.comSHAREHOLDER ALERT: Weiss Law Reminds IMRA, TIG, FORG, and BRBW Shareholders About Its Ongoing InvestigationsJanuary 5, 2023 | benzinga.comSee More Headlines IMRA Stock Analysis - Frequently Asked Questions How were IMARA's earnings last quarter? IMARA Inc. (NASDAQ:IMRA) issued its quarterly earnings data on Tuesday, November, 9th. The company reported ($2.20) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($3.64) by $1.44. When did IMARA's stock split? IMARA's stock reverse split on Friday, February 24th 2023.The 1-4 reverse split was announced on Friday, February 24th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. When did IMARA IPO? IMARA (IMRA) raised $76 million in an IPO on Thursday, March 12th 2020. The company issued 4,500,000 shares at a price of $16.00-$18.00 per share. Morgan Stanley, Citigroup and SVB Leerink served as the underwriters for the IPO. What other stocks do shareholders of IMARA own? Based on aggregate information from My MarketBeat watchlists, some other companies that IMARA investors own include NIO (NIO), Novavax (NVAX), NVIDIA (NVDA), Axsome Therapeutics (AXSM), Alibaba Group (BABA), AMC Entertainment (AMC) and BioXcel Therapeutics (BTAI). Company Calendar Last Earnings11/09/2021Today8/02/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:IMRA CIK1672619 Webwww.imaratx.com PhoneN/AFaxN/AEmployees41Year FoundedN/AProfitability EPS (Trailing Twelve Months)$0.05 Trailing P/E Ratio768.95 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.49 million Net MarginsN/A Pretax MarginN/A Return on Equity2.12% Return on Assets2.00% Debt Debt-to-Equity RatioN/A Current Ratio48.98 Quick Ratio48.98 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.51 per share Price / Cash Flow75.24 Book Value$3.44 per share Price / Book11.17Miscellaneous Outstanding Shares26,234,000Free Float16,449,000Market Cap$1.01 billion OptionableNot Optionable Beta1.09 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NASDAQ:IMRA) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersMicrosoft's Next Big Bet?Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-fre...Stansberry Research | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMARA Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMARA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.